HMG is a complex glycoprotein hormone, so it behaves differently from synthetic peptides like BPC-157 or Ipamorelin during HPLC testing. Its structure can produce multiple peaks, making a single purity percentage inaccurate.

Instead, its quality is assessed through identity and hormone content, which are more meaningful measures for this product.

IU measures biological activity, while independent laboratory testing measures the amount of hormone by weight. Direct activity testing requires specialized bioassays that are not typically available through independent laboratories.

For HMG, the laboratory reports hormone content by weight because its FSH and LH components cannot be combined into a single IU value through standard testing.

In short, these lab reports measure hormone identity and content, not biological potency. Differences from the labeled IU do not necessarily indicate a problem with the batch.

HMG contains both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) bioactivity, enabling simultaneous investigation of follicle-stimulating hormone receptor (FSHR) and luteinizing hormone/choriogonadotropin receptor (LHCGR) signaling pathways. This combined receptor activity makes HMG a useful research tool for studying gonadotropin receptor pharmacology, receptor-ligand interactions, comparative GPCR signaling mechanisms, and the relationship between FSHR- and LHCGR-mediated signal transduction processes.

HMG contains multiple glycoprotein hormone isoforms exhibiting varying degrees of glycosylation and sialylation, whereas recombinant preparations are generally characterized by more defined glycoform profiles. This molecular heterogeneity has made HMG valuable for investigations examining glycoprotein hormone structure-function relationships, receptor binding characteristics, glycoform-dependent signaling behavior, and the influence of glycosylation patterns on receptor activation kinetics.

FSHR and LHCGR are members of the G protein-coupled receptor (GPCR) superfamily that primarily signal through Gsα-mediated activation of adenylyl cyclase, resulting in intracellular cAMP generation and protein kinase A (PKA) activation. These receptors are widely utilized in research examining GPCR signaling dynamics, receptor activation mechanisms, second-messenger systems, receptor-ligand interactions, and downstream signal transduction pathways associated with glycoprotein hormone receptor biology.